First gonorrhoea antibiotics in decades herald new era of treatment
Entasis’ Nuzolvence and GSK’s Blujepa are the first antibiotic approvals in gonorrhoea in over 30 years in the US.
Therapy Area
Sanofi shares fall 6% after double setback for MS drug tolebrutinib
Mirum to buy Bluejay for up to $820m in rare liver disease push
Pfizer gains another obesity asset with $2bn deal for YaoPharma’s GLP-1RA
Crescent and Kelun-Biotech swap cancer asset rights in double deal
WHO backs use of GLP-1RAs for weight loss despite shortage warning
“Sharp” funding cuts disrupt PrEP access to millions of HIV patients
Dupixent gains chronic spontaneous urticaria indication in Europe
